DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer

To prospectively collect medical images and clinical data related to esophageal cancer using 4D Free Breathing DCE-MRI technology, to evaluate the image quality in the diagnosis of esophageal cancer, and to predict the efficacy of preoperative neoadjuvant chemoradiotherapy for esophageal cancer.

Trial Details

NCT ID
NCT06755866
Phase
NA
Sponsor
Yunnan Cancer Hospital
Status
RECRUITING
Cancer Type
Esophageal Cancer
Interventions
  • The application value of MRI 4D Free Breathing DCE-MRI in the treatment of esophageal cancer
Locations (sample)
  • Kunming, Yunnan, China|25.03889,102.71833

Key Eligibility Criteria

  • Be 18 years of age and older;
  • First diagnosis of esophageal squamous cell carcinoma confirmed by histopathological biopsy;
  • The clinical stage is cT1b\~cT2N+; or the clinical stage is cT3\~cT4 any N, (thoracic esophageal cancer, esophagogastric junction cancer);
  • There are no contraindications to MRI examination

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Esophageal Cancer Trials on Trialify →